The combination of cash and cannabis has proved a heady mix for the sharemarket recently. But nothing prepared the Australian market for the astounding reaction to Tuesday’s news that the “King of Cannabis” Nevil Schoenmakers is acting as a strategic adviser to another dope hope, the ASX-listed Singaporean biotech Stemcell United. Read story.